Metabolic and genetic contributions to NAFLD: Really distinct and homogeneous?-Reference-Cited by-同舟云学术

Metabolic and genetic contributions to NAFLD: Really distinct and homogeneous?

Published:2021-12 Issue: Volume: Page:
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Speliotes Elizabeth K.,George Jacob

Publisher

Elsevier BV

Subject

Hepatology

Reference23 articles.

1. Insulin resistance exacerbates genetic predisposition to nonalcoholic fatty liver disease in individuals without diabetes;Barata;Hepatol Commun,2019

2. Metabolic signature of obesity-associated insulin resistance and type 2 diabetes;Al-Sulaiti;J Transl Med,2019

3. Stable isotope-based flux studies in nonalcoholic fatty liver disease;McCullough;Pharmacol Ther,2018

4. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease;Donnelly;J Clin Invest,2005

5. NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects;Sliz;Hum Mol Genet,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives;Hepatology International;2024-06-16

2. Fenofibrate alleviates NAFLD by enhancing the PPARα/PGC-1α signaling pathway coupling mitochondrial function;BMC Pharmacology and Toxicology;2024-01-03

3. Therapeutic potential of bioactive phytoconstituents found in fruits in the treatment of non-alcoholic fatty liver disease: A comprehensive review;Heliyon;2023-04

4. Vitamin D improves hepatic steatosis in NAFLD via regulation of fatty acid uptake and β-oxidation;Frontiers in Endocrinology;2023-03-22

5. Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges;Therapeutic Advances in Endocrinology and Metabolism;2023-01